Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01

D-0877-2023

May 18, 2023

Class III

Product summary

Firm
Aurolife Pharma, LLC
Event
Event 92379
Status
Terminated
Classification
Class III
Quantity
Unavailable
Official record key
drug-enforcement:D-0877-2023

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot #: 01421038A1, Exp. Date 05/2023

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications